All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

54

Reset

54 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • SKB264MK-2870, Sacituzumab TirumotecanPhase 353 trials

    Merck & Co. · Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Cervical Cancer

  • RilvegostomigAZD2936Phase 325 trials

    AstraZeneca · Biliary Tract Cancer, Gastric Cancer, Non-small Cell Lung Cancer

  • SintilimabIBI308Phase 321 trials

    Innovent Biologics (Suzhou) Co. Ltd. · Hepatocellular Carcinoma, Solid Tumor, HCC - Hepatocellular Carcinoma

  • VolrustomigMEDI5752Phase 313 trials

    AstraZeneca · Gastric Cancer, Non-small Cell Lung Cancer, Biliary Tract Cancer

  • Anlotinib hydrochlorideAL3818, CatequentenibPhase 312 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Alveolar Soft Part Sarcoma, Metastatic Colorectal Cancer, Endometrial Neoplasms

  • SaruparibAZD5305Phase 310 trials

    AstraZeneca · Prostate Cancer, Ovarian Cancer, Endometrial Cancer

  • FavezelimabMK-4280, MK-4820APhase 39 trials

    Merck & Co. · Melanoma, Carcinoma, Renal Cell, Solid Tumors

  • Rina-SPRO1184, GEN1184Phase 39 trials

    Genmab · Ovarian Cancer, Platinum-resistant Ovarian Cancer, Endometrial Cancer

  • Mocertatug rezetecanMo-RezPhase 36 trials

    GSK · Ovarian Neoplasms, Neoplasms, Endometrial, Tumours, Gynecological

  • OlomorasibLY3537982Phase 36 trials

    Eli Lilly · Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Neoplasm Metastasis

  • DB-1303BNT323, trastuzumab pamirtecanPhase 35 trials

    DualityBio Inc. · Metastatic Breast Cancer, HER2-positive Advanced Solid Tumor, Endometrial Cancer

  • AL8326Phase 34 trials

    Advenchen Pharmaceuticals, LLC. · Endometrial Neoplasms, Soft Tissue Sarcoma (STS), Breast Neoplasms

  • AZD5335Torvutatug samrotecan, Torvu-samPhase 34 trials

    AstraZeneca · Epithelial Ovarian Cancer, Ovarian Cancer, Lung Adenocarcinoma

  • HB0025Phase 34 trials

    Shanghai Huaota Biopharmaceutical Co., Ltd. · First-line pMMR Endometrial Cancer, Non Squamous Non-small Cell Lung Cancer, TNBC

  • KRT-232NavtemadlinPhase 34 trials

    Kartos Therapeutics, Inc. · Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma

  • HS-20089Phase 33 trials

    Hansoh BioMedical R&D Company · Ovarian Cancer, Platinum-sensitive Recurrent Ovarian Cancer, Fallopian Tube Cancer

  • EG-007Phase 32 trials

    Evergreen Therapeutics, Inc. · Advanced Endometrial Cancer

  • TQB2450Phase 32 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Endometrial Cancer, Non Small Cell Lung Cancer

  • TR115Phase 32 trials

    Tarapeutics Science Inc. · Ovarian Clear Cell Carcinoma, Endometrial Cancer, Stomach Cancer Recurrent

  • Olaparib phasePhase 31 trial

    AstraZeneca · Advanced or Recurrent Endometrial Cancer

  • PalacaparibAZD9574Phase 25 trials

    AstraZeneca · Metastatic Prostate Cancer, Ovarian Cancer, Endometrial Cancer

  • EnvafolimabPhase 24 trials

    3D Medicines (Sichuan) Co., Ltd. · Biliary Tract Neoplasms, Solid Tumor, Solid Tumors

  • TUB-040Phase 24 trials

    Gilead Sciences · Ovarian Cancer, Non-small Cell Lung Cancer, Uterine Endometrial Cancer

  • UbamatamabREGN4018Phase 24 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • GV20-0251Phase 23 trials

    GV20 Therapeutics · Endometrial Carcinoma (EC), Squamous Head and Neck Carcinoma, pMMR/MSS Adenocarcinoma of the Colon or Rectum

  • INCAGN02385Phase 23 trials

    Incyte · Melanoma, Endometrial Cancer, Head and Neck Cancer

  • INCAGN02390Phase 23 trials

    Incyte · Melanoma, Endometrial Cancer, Head and Neck Cancer

  • TulmimetostatDZR123, Tulmimetostat DL1Phase 23 trials

    Novartis · Progressive Metastatic Castrate Resistant Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Advanced Solid Tumor

  • AL58805Phase 22 trials

    Advenchen Pharmaceuticals, LLC. · Endometrial Neoplasms, Soft Tissue Sarcoma (STS), Breast Neoplasms

  • AVZO-021Phase 22 trials

    Avenzo Therapeutics, Inc. · HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer, Advanced Solid Tumor

  • Fianlimab [Fixed ]Phase 22 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • SapanisertibFTH-003, MLN0128Phase 22 trials

    Faeth Therapeutics · Endometrial Cancer, HR+ HER2- Breast Cancer

  • SerabelisibFTH-001, MLN1117Phase 22 trials

    Faeth Therapeutics · Endometrial Cancer, HR+ HER2- Breast Cancer

  • TCC1727Phase 22 trials

    Beijing Tide Pharmaceutical Co., Ltd · Patients with Advanced Solid Tumors, Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer)

  • vudalimabPhase 22 trials

    Xencor, Inc. · Ovarian Cancer, Clear Cell Carcinoma, Endometrial Cancer

  • ACR-368prexasertibPhase 21 trial

    Acrivon Therapeutics · Endometrial Adenocarcinoma

  • ART0380Phase 21 trial

    Artios Pharma Ltd · Advanced Cancer, Metastatic Cancer, Ovarian Cancer

  • AZD8205Phase 21 trial

    AstraZeneca · Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer

  • BMX-001Phase 21 trial

    BioMimetix JV, LLC · Ovarian Neoplasms, Endometrial Cancer, Endometrial Neoplasm

  • CR-002Phase 21 trial

    Crescent Biopharma, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)

  • DM002Phase 21 trial

    Xadcera Biopharmaceutical (Suzhou) Co., Ltd. · Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

  • E7386Phase 21 trial

    Eisai · Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular

  • EIK1005Phase 21 trial

    Eikon Therapeutics · Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors, MSI-H/dMMR Gastric Cancer

  • epacadostatPhase 21 trial

    Incyte · Endometrial Cancer

  • ETX-929Phase 21 trial

    Ensem Therapeutics · Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer

  • GSK4418959Phase 21 trial

    GSK · Neoplasms, Colorectal, Solid Tumor, Colon Cancer

  • INV-6452Phase 21 trial

    Shenzhen Ionova Life Sciences Co., Ltd. · Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer

  • INV-8989Phase 21 trial

    Shenzhen Ionova Life Sciences Co., Ltd. · Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC

  • LG00313112Phase 21 trial

    LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer

  • MDX2001Phase 21 trial

    ModeX Therapeutics, An OPKO Health Company · Biliary Tract Cancer, Breast Cancer, Cervical Cancer

Page 1 of 2Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.